Conventional versus high-dose epidoxorubicin as single agent in advanced breast cancer.

Abstract:

:Between March 1986 and December 1987, two groups of consecutive patients with advanced breast cancer underwent epidoxorubicin (Epidx) monochemotherapy. Twenty-three patients (group A) received Epidx at a dose of 60 mg/m2 and 27 (group B) at a dose of 120 mg/m2 (i.v. every 3 weeks). No patient had undergone anthracycline treatment before entering the study. Age ranged from 39 to 70 years (mean 52) in group A and from 35 to 69 (mean 50 in group B). The main sites of involvement were liver (5 patients in group A and 10 in group B), lung (4 and 5 patients, respectively), bone (7 and 8 patients, respectively), and soft tissue (6 and 5 patients, respectively). The number of courses of therapy ranged from 4 to 10 (mean 7.4) in group A and from 3 to 10 (mean 6.6) in group B. Tumor response and toxic effects were graded according to World Health Organization criteria. CR + PR were 35% in group A and 67% in group B (chi square = 3.862, p < 0.05). Results were analyzed at 130 weeks from the beginning of the therapy. At this time, survival was 9% in group A and 15% in group B, with a median survival time of 61 weeks (range 18-130) and 77 weeks (range 24-130), respectively. No patient in group A showed cardiac toxicity higher than grade 2 during or after the treatment, whereas in group B, 2 patients developed congestive heart failure after a cumulative Epidx dose of 1080 and 1200 mg/m2. Treatment delays, to allow recovery of white blood cells, were infrequent and occurred only in patients previously subjected to chemotherapy. No patient required hospitalization for sepsis, and alopecia was reversible in all patients. Our data demonstrate that there is a relationship between Epidx dose and response rate in advanced breast cancer.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Neri B,Pacini P,Algeri R,Lottini G,Rinaldini M,Tucci E,Pusterla R

doi

10.3109/07357909309024827

subject

Has Abstract

pub_date

1993-01-01 00:00:00

pages

106-12

issue

2

eissn

0735-7907

issn

1532-4192

journal_volume

11

pub_type

临床试验,杂志文章
  • Immune signatures predict prognosis in localized cancer.

    abstract::The host immune response can impact cancer growth, prognosis, and response to therapy. In colorectal cancer, the presence of cells involved with T-cell-mediated adaptive immunity predicts survival better than the current staging method. We used the expression of genes recently associated with host immune responses (T(...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903095755

    authors: Hsu DS,Kim MK,Balakumaran BS,Acharya CR,Anders CK,Clay T,Lyerly HK,Drake CG,Morse MA,Febbo PG

    更新日期:2010-08-01 00:00:00

  • Phase II trial of paclitaxel in patients with soft-tissue sarcoma.

    abstract::The response rate (RR) to single-agent chemotherapy with doxorubicin or ifosfamide in patients with advanced soft-tissue sarcoma (STS) is in the range of 20%. Paclitaxel is clinically useful in treating several solid tumors and has demonstrated activity in a series of human sarcoma cell lines. Twenty-eight patients wi...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909809011697

    authors: Casper ES,Waltzman RJ,Schwartz GK,Sugarman A,Pfister D,Ilson D,Woodruff J,Leung D,Bertino JR

    更新日期:1998-01-01 00:00:00

  • Thrombin expression in prostate: a novel finding.

    abstract:INTRODUCTION:A variable repertoire of coagulation protein expression is observed in different cancers. We evaluated expression of thrombin in prostate tissue. METHODS:Detection of thrombin was performed using quantitative real-time PCR in fresh tissue and in situ hybridization (ISH) in archival prostate tissue and by ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2010.535057

    authors: Kohli M,Williams K,Yao JL,Dennis RA,Huang J,Reeder J,Ricke WA

    更新日期:2011-01-01 00:00:00

  • Introduction to genetic linkage analysis.

    abstract::Advances in molecular methodology have resulted in the successful genetic mapping and isolation of the genes responsible for numerous simple Mendelian disorders such as cystic fibrosis, neurofibromatosis, and Huntington disease. Recently, researchers have begun to successfully study diseases with more complex inherita...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709047596

    authors: Foroud T

    更新日期:1997-01-01 00:00:00

  • Usefulness of thallium-201 SPECT scintimammography to differentiate benign from malignant breast masses in mammographically dense breasts.

    abstract::The purpose of this study was to assess the usefulness of thallium-201 (Tl-201) single-photon emission-computed tomography (SPECT) scintimammography to differentiate benign from malignant breast masses in 32 female Taiwanese patients with indeterminate mammographic probability of malignancy because of mammographically...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120025089

    authors: Chiou JF,Lin MC,Chen DR,Jim YF,Kao CH

    更新日期:2003-01-01 00:00:00

  • Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.

    abstract::Effect of advanced glycation end products (AGEs) in the pathogenesis of cancer could be diminished by interaction with soluble RAGE or by reducing AGE-precursors via glyoxalase I. Glu111Ala polymorphism of glyoxalase I gene, AGEs, and sRAGE serum levels were studied in 113 breast cancer patients and in 58 controls. Hi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802350822

    authors: Germanová A,Germanová A,Tesarová P,Jáchymová M,Zvára K,Zima T,Kalousová M

    更新日期:2009-07-01 00:00:00

  • Investigation of Human Cytomegalovirus and Human Papillomavirus in Glioma.

    abstract::The study investigated the human cytomegalovirus (HCMV) and human papillomavirus (HPV) in gliomas. A retrospective study was conducted on 112 samples. HCMV was investigated by PCR, in situ hybridization (ISH) and immunohistochemistry. HPV was tested by PCR and DNA ISH. HCMV was identified in 60 gliomas, including 55 G...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1793352

    authors: Limam S,Missaoui N,Hmissa S,Yacoubi MT,Krifa H,Mokni M,Selmi B

    更新日期:2020-08-01 00:00:00

  • Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology Group.

    abstract::Based on a preliminary trial that suggested that CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone), and PVB (cisplatinum, vinblastine, bleomycin), are at least partially non-cross-resistant, the Southwest Oncology Group treated patients with unfavorable histology, non-Hodgkin's lymphoma with CHOP and PVB. ...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357909109039872

    authors: Dabich L,Dahlberg S,Hartsock RJ,LoBuglio AF,Liepman MK,Grozea PN,Eyre HJ,Weick JK,Bonnet JD,Coltman CA Jr

    更新日期:1991-01-01 00:00:00

  • UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies.

    abstract::UFT is the combination of the fluorouracil (5-FU) prodrug tegafur, and the dihydrophyrimidine dehydrogenase inhibitor uracil. UFT and leucovorin have been used in the oral treatment of a variety of malignancies. Given the radiosensitizing properties of UFT, its combination with radiation therapy is a logical step in t...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120022382

    authors: Saad ED,Hoff PM

    更新日期:2003-01-01 00:00:00

  • Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development.

    abstract::Methylation pattern is presented here for first time as a potential molecular marker of changes on SSTR2A and SHP-1(I) gene promoter related to breast and prostate carcinoma. Our results have shown low concordances with SSTR2A and methylated state in prostate cancer and moderate relationship with unmethylated CpG-27 i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.1001892

    authors: Tiscornia MM,González HS,Lorenzati MA,Zapata PD

    更新日期:2015-03-01 00:00:00

  • Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.

    abstract::The purpose of this study was to clarify the mechanism of IFN-α resistance in RCC. The effects of IFN-α on induction of apoptosis and cell-cycle arrest were analyzed by flow cytometric analysis. Jak-Stat pathway components induced by IFN-α was evaluated using Western blotting. The results suggested that IFN-α caused g...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.568566

    authors: Shang D,Yang P,Liu Y,Song J,Zhang F,Tian Y

    更新日期:2011-06-01 00:00:00

  • Chromosome breaks and genomic instability.

    abstract::Tumorigenesis is known to result from multiple genetic changes. Although endogenous and environmental insults can damage DNA, cellular mechanisms exist to repair various forms of damage or to kill those cells irreparably damaged. Hence, the accumulation of numerous genetic changes that would lead to cancer in normal c...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357900009023065

    authors: Jasin M

    更新日期:2000-01-01 00:00:00

  • Detection of Promoter DNA Methylation of APC, DAPK, and GSTP1 Genes in tissue Biopsy and Matched Serum of Advanced-Stage Lung Cancer Patients.

    abstract::Promoter DNA hypermethylation of APC, DAPK, and GSTP1 genes was evaluated in biopsy and matched serum of 160 lung cancer patients and 70 controls. In biopsy, 83.1, 83.1, and 78.1% of lung cancer patients and 72.9, 70, and 70% of controls, while in serum, 52.5, 30.6, and 65.6% of lung cancer patients and 14.3, 18.6, an...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2017.1309547

    authors: Ali A,Kumar S,Kakaria VK,Mohan A,Luthra K,Upadhyay AD,Guleria R

    更新日期:2017-07-03 00:00:00

  • Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.

    abstract::Following is a review of altered fractionation in radiation therapy for head and neck cancer. The goals of altered fractionation are to increase local-regional control and/or reduce the risk of late complications. Altered fractionation schedules can be broadly classified as accelerated fractionation and hyperfractiona...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909809032890

    authors: Mendenhall WM,Parsons JT

    更新日期:1998-01-01 00:00:00

  • A novel 3-d model of chick chorioallantoic membrane for ameliorated studies in angiogenesis.

    abstract::Decisive indulgence of angiogenesis requires a more holistic assessment and several in vivo assays have been developed that permit a more realistic appraisal of the angiogenic response. One of the most popular assays to study angiogenic activity is the chick chorioallantoic membrane (CAM). Although CAM assay is a vita...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600894773

    authors: Ejaz S,Chekarova I,Ashraf M,Lim CW

    更新日期:2006-10-01 00:00:00

  • Computer visualization techniques (CVTs) foster evidence-based target delineation.

    abstract::Computer visualization techniques (CVTs) are an emerging technology that can organize all cancer specialists. This article describes CVTs' ability to maximize the currently untapped advantages of intensity modulated radiotherapy (IMRT). The visual speed and dynamic strategies inherent in CVTs improves IMRT by distilli...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600970490

    authors: Butler EB,Shukla V,Paulino AC,Lu HH,Butler R,Smiedala M,Kurk J,Grant WH 3rd,McGary JE,Teh BS

    更新日期:2007-02-01 00:00:00

  • A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

    abstract::Standard chemotherapeutic regimens, such as cisplatin and etoposide, may improve quality of life and prolong survival in patients with incurable non-small cell lung cancer (NSCLC). This trial was designed to evaluate the activity and toxicity of a regimen combining three of the most active agents against advanced-stag...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357900009023055

    authors: Ali MA,Kraut MJ,Valdivieso M,Wozniak AJ,Cummings G,Kalemkerian GP

    更新日期:2000-01-01 00:00:00

  • Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.

    abstract::We analyzed the pattern of alpha-fetoprotein (AFP) synthesis in 40 consecutive human hepatocarcinomas (HCC) in relation to hepatitis B viral (HBV) infection. In addition, histopathological characteristics of liver parenchyma and the tumor itself were examined. Elevated AFP (> 20 ng/ml) were found in 90% of HCC patient...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909209024813

    authors: Kashala LO,Kalengayi MM,Essex M

    更新日期:1992-01-01 00:00:00

  • Anti-angiogenic treatment of gastrointestinal malignancies.

    abstract::The scientific rationale to block angiogenesis as a treatment strategy for human cancer has been developed over the last 30 years, but is only now entering the clinical arena. Preclinical studies have demonstrated the importance of the vascular endothelial growth factor (VEGF) pathways in both physiologic and patholog...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900500360024

    authors: Salmon JS,Lockhart AC,Berlin J

    更新日期:2005-01-01 00:00:00

  • Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.

    abstract::To identify the relevant CpG sites as molecular markers, for the diagnosis and to distinguish the indolent and aggressive prostate tumors, we have determined the methylation status of 8 genes, including FLNC, EFS, ECRG4, RARB2, PITX2, GSTP1, PDLIM4, and KCNMA1 in 32 nonrecurrent, 32 recurrent primary prostate tumors, ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802620794

    authors: Vanaja DK,Ehrich M,Van den Boom D,Cheville JC,Karnes RJ,Tindall DJ,Cantor CR,Young CY

    更新日期:2009-06-01 00:00:00

  • Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.

    abstract::Arsenic trioxide is valuable for treatment of promyelocytic leukemia, but less attention has been paid to its therapeutic potential for other cancers. In this study, the effects of arsenic trioxide were tested in human pancreatic (AsPC-1), colonic (HT-29), and breast (MCF-7) cancer cells. In all three cancer cell line...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-200029068

    authors: Li X,Ding X,Adrian TE

    更新日期:2004-01-01 00:00:00

  • Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer.

    abstract::Fulvestrant (Faslodex) is a new type of estrogen receptor (ER) antagonist that binds, blocks, and degrades the ER, leading to reduced expression of the progesterone receptor (PgR). Unlike the selective ER modulator tamoxifen, fulvestrant is devoid of any known agonist activity. Fulvestrant has a steroidal structure th...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-50480

    authors: Bundred N

    更新日期:2005-01-01 00:00:00

  • Nerve growth factor receptor immunoreactivity in breast cancer patients.

    abstract::Nerve growth factor receptor (NGF-R) has been shown to have antiproliferative, differentiative, or apoptotic effects on some types of tumor cells, whereas in others it may have mitogenic activity. The immunohistochemical distribution of NGF-R was analyzed in a series of tissue samples from breast cancer patients and i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100106144

    authors: Aragona M,Panetta S,Silipigni AM,Romeo DL,Pastura G,Mesiti M,Cascinu S,La Torre F

    更新日期:2001-01-01 00:00:00

  • Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.

    abstract::The transforming growth factor beta 1 (TGF-beta1) is a multifunctional cytokine with several regulatory activities in tumor cells affecting growth, differentiation, and function. Alterations in gene expression, secretion, and regulation of TGF-beta1 may lead to a favorable environment for tumor development by angiogen...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701600921

    authors: Faria PC,Saba K,Neves AF,Cordeiro ER,Marangoni K,Freitas DG,Goulart LR

    更新日期:2007-12-01 00:00:00

  • A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.

    abstract::This study compared the antiemetic efficacy and safety of two different intravenous (i.v.) dolasetron dosing regimens in patients receiving their first course of high-dose (> or = 80 mg/m2) cisplatin. Of 30 patients enrolled, 14 received a single i.v. dolasetron dose (0.6 mg/kg) before cisplatin and 16 received a mult...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.3109/07357909709039730

    authors: Kasimis BS,Tapazoglou E,Schulman P,Stewart WH,Hahne WF,Cramer MB

    更新日期:1997-01-01 00:00:00

  • Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.

    abstract::Renal cell carcinoma is the most common tumor of the kidney. It has an unpredictable behavior and poor response to systemic therapy. Developing newer therapy for this disease is a priority considering the high recurrence rate and the small subset of patients who benefit from the use of cytokines such as interferon-alp...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900600896315

    authors: Shaheen PE,Bukowski RM

    更新日期:2006-10-01 00:00:00

  • Chemo/radiotherapy-Induced Bone Marrow Niche Alterations.

    abstract::Bone marrow (BM) niche is a specific microenvironment for hematopoietic stem cells (HSCs) as well as non-hematopoietic cells. Evidence shows that chemo/radiotherapy can lead to the disruption of different properties of HSCs such as proliferation, differentiation, localization, self-renewa, and steady-state of cell pop...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1855353

    authors: Rafieemehr H,Maleki Behzad M,Azandeh S,Farshchi N,Ghasemi Dehcheshmeh M,Saki N

    更新日期:2020-12-10 00:00:00

  • In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.

    abstract::In vivo and in vitro observations of cellular immune response in 70 patients with squamous cell cancer of the oral cavity and in 40 age-matched normal controls, were made using delayed hypersensitivity responses to DNCB, PPD, and Candida albicans extract (Dermatophytin 'O'), absolute lymphocyte counts, absolute T-cell...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609018450

    authors: Das SN,Khanna NN,Khanna S

    更新日期:1986-01-01 00:00:00

  • Clinical significance of erbB-2 (HER-2/neu) protein.

    abstract::erbB-2 protein is believed to be a cell membrane receptor for the recently identified ligand gp30. When overexpressed, erbB-2 is an indicator of poor prognosis in adenocarcinomas of breast, stomach, lung, and endometrium. Even more important, clinical data suggest that erbB-2 overexpression may be an indicator of poor...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909209024819

    authors: Paik S

    更新日期:1992-01-01 00:00:00

  • Emotional Response of US Breast Cancer Survivors during the COVID-19 Pandemic.

    abstract::In a sample of 633 US adult breast cancer survivors, we examined health-related worry as a function vulnerability as influenced by communication, trust, and planning with their cancer care team during the COVID-19 pandemic. We found significant positive correlations between communication and trust, communication and p...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1841220

    authors: Papautsky EL,Hamlish T

    更新日期:2021-01-01 00:00:00